Doug Coyle
Biographic Data
| ID | 5412663 |
|---|---|
| NAME | Doug Coyle |
| GIVEN NAMES | Doug |
| FAMILY NAME | Coyle |
| SIGNATURE | COYLE D |
| AFFILIATIONS | University of Ottawa |
| ORCID | 0000-0003-3492-2268 |
| VERIFIED | Yes |
| TOTAL WORKS | 14 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 14 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 1994 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
Relationship Between Gestational Weight Gain and Health Service Utilization in Early Childhood
Utility gains from reductions in the modifiable burden of lung cancer attributable to residential radon in Canada
Effectiveness of a hospital-initiated smoking cessation programme
Considering the relatively low cost, greater adoption of hospital-initiated tobacco cessation interventions should be considered to improve patient outcomes and decrease subsequent healthcare usage
Children With Mild Bilateral and Unilateral Hearing Loss
Children with mild bilateral and unilateral hearing loss are now commonly identified early through newborn hearing screening initiatives. There remains considerable uncertainty about how to support parents and about which services to provide for children with mild bilateral and unilateral hearing loss. The goal of this study was to learn about parents' experiences and understand, from their perspectives, the impact of hearing loss in the mild ran…
Economic evaluation of a hospital-initiated intervention for smokers with chronic disease, in Ontario, Canada
The OMSC appears to be cost-effective from the hospital payer perspective. Important consideration is the relatively low intervention cost compared to the reduction in costs related to readmissions for illnesses associated with continued smoking
Developing and Testing a Tool for Assessing Pharmacoeconomic Evaluations
Introduction Manufacturers seeking reimbursement from publicly funded drug plans submit a drug submission to the Common Drug Review (CDR). This includes clinical data and a pharmacoeconomic evaluation (PE) which is assessed by clinical and economic teams. Clinical and pharmacoeconomic reports are used by the Canadian Drug Expert Committee (CDEC) in their deliberations, which could result in a “do not list”, “list with criteria” or “list” formular…
Resource Allocation for the Treatment of Rare Diseases
Introduction Drugs for rare diseases are often associated with extremely high costs which can be a barrier to patients' accessibility. Due to scarce healthcare resources, funding for expensive orphan therapies is a predicament for policy-makers and patients. In Canada, funding decisions for drugs for rare diseases are made at the provincial and regional level primarily on an individual basis, and are typically made on the grounds of historical an…
The Epidemiology and Health System Impact of Medium-Chain Acyl-Coa Dehydrogenase Deficiency Among Affected Children and Those With False Positive Newborn Screening Results in Ontario, Canada
Introduction Limited research has focused on the health system impact of rare genetic disorders, including inborn errors of metabolism (IEM). Investigating patterns of health services use and their association with social and geographic characteristics is important for understanding the burden of disease, including the impact of screening and clinical management; and for identifying potential inequities in access to care. Objectives We conducted …
Depressive Symptoms Are Associated with Medication Use and Lower Health-Related Quality of Life in Overweight Women with Binge Eating Disorder
Validity of information obtained from a method for estimating cancer costs from the perspective of patients and caregivers
Exploring informed choice in the context of prenatal testing
Purpose This study explored whether and how a sample of women made informed choices about prenatal testing for foetal anomalies; its aim was to provide insights for future health policy and service provision. Methods We conducted semi‐structured interviews with 38 mothers in Ottawa, Ontario, all of whom had been offered prenatal tests in at least one pregnancy. Using the Multi‐dimensional Measure of Informed Choice as a general guide to analysis,…
Constructing health state preference values from descriptive quality of life outcomes
Envisioning the Future Welfare State
Current status of economic appraisal of health technology in the European community
No prominent works on this page.
Current status of economic appraisal of health technology in the European community
Constructing health state preference values from descriptive quality of life outcomes
Envisioning the Future Welfare State
Exploring informed choice in the context of prenatal testing
Purpose This study explored whether and how a sample of women made informed choices about prenatal testing for foetal anomalies; its aim was to provide insights for future health policy and service provision. Methods We conducted semi‐structured interviews with 38 mothers in Ottawa, Ontario, all of whom had been offered prenatal tests in at least one pregnancy. Using the Multi‐dimensional Measure of Informed Choice as a general guide to analysis,…
Depressive Symptoms Are Associated with Medication Use and Lower Health-Related Quality of Life in Overweight Women with Binge Eating Disorder
Validity of information obtained from a method for estimating cancer costs from the perspective of patients and caregivers
Developing and Testing a Tool for Assessing Pharmacoeconomic Evaluations
Introduction Manufacturers seeking reimbursement from publicly funded drug plans submit a drug submission to the Common Drug Review (CDR). This includes clinical data and a pharmacoeconomic evaluation (PE) which is assessed by clinical and economic teams. Clinical and pharmacoeconomic reports are used by the Canadian Drug Expert Committee (CDEC) in their deliberations, which could result in a “do not list”, “list with criteria” or “list” formular…
Resource Allocation for the Treatment of Rare Diseases
Introduction Drugs for rare diseases are often associated with extremely high costs which can be a barrier to patients' accessibility. Due to scarce healthcare resources, funding for expensive orphan therapies is a predicament for policy-makers and patients. In Canada, funding decisions for drugs for rare diseases are made at the provincial and regional level primarily on an individual basis, and are typically made on the grounds of historical an…
The Epidemiology and Health System Impact of Medium-Chain Acyl-Coa Dehydrogenase Deficiency Among Affected Children and Those With False Positive Newborn Screening Results in Ontario, Canada
Introduction Limited research has focused on the health system impact of rare genetic disorders, including inborn errors of metabolism (IEM). Investigating patterns of health services use and their association with social and geographic characteristics is important for understanding the burden of disease, including the impact of screening and clinical management; and for identifying potential inequities in access to care. Objectives We conducted …
Economic evaluation of a hospital-initiated intervention for smokers with chronic disease, in Ontario, Canada
The OMSC appears to be cost-effective from the hospital payer perspective. Important consideration is the relatively low intervention cost compared to the reduction in costs related to readmissions for illnesses associated with continued smoking
Effectiveness of a hospital-initiated smoking cessation programme
Considering the relatively low cost, greater adoption of hospital-initiated tobacco cessation interventions should be considered to improve patient outcomes and decrease subsequent healthcare usage
Children With Mild Bilateral and Unilateral Hearing Loss
Children with mild bilateral and unilateral hearing loss are now commonly identified early through newborn hearing screening initiatives. There remains considerable uncertainty about how to support parents and about which services to provide for children with mild bilateral and unilateral hearing loss. The goal of this study was to learn about parents' experiences and understand, from their perspectives, the impact of hearing loss in the mild ran…
Utility gains from reductions in the modifiable burden of lung cancer attributable to residential radon in Canada
Relationship Between Gestational Weight Gain and Health Service Utilization in Early Childhood
Medicine (13 works) · Psychology (6 works) · Environmental health (5 works) · Family medicine (5 works) · Health care (5 works) · Health Systems, Economic Evaluations, Quality of Life (5 works) · Nursing (5 works) · Population (5 works) · Internal Medicine (4 works) · Computer Science (3 works)